Solstice Advanced Materials Inc. (SOLS) - Q1 2026 10-Q Summary
Business Context and Reporting Period
Solstice Advanced Materials Inc. is a global specialty chemicals and advanced materials company operating through two segments: Refrigerants & Applied Solutions (RAS) and Electronic & Specialty Materials (ESM). The company became an independent, publicly traded entity following a spin-off from Honeywell International Inc. on October 30, 2025. This report covers the quarterly period ended March 31, 2026.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $991 million | $897 million |
| Gross Profit | $317 million | $321 million |
| Net Income (GAAP) | $105 million | $140 million |
| Net Income Attributable to Solstice | $85 million | $134 million |
| Diluted EPS | $0.53 | $0.85 |
| Adjusted EBITDA (Non-GAAP) | $249 million | $271 million |
| Operating Cash Flow | $199 million | $160 million |
| Cash and Equivalents | $642 million | $668 million |
| Total Debt (Carrying Value) | $2.065 billion | $2.072 billion |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10% year-over-year, driven by volume growth (5.6%), favorable pricing (2.4%), and foreign currency translation (2.5%).
- Profitability Decline: Net income attributable to Solstice decreased 37% to $85 million. This was primarily due to a significant increase in interest and other financial charges ($29 million vs. $1 million in Q1 2025) resulting from debt issuance associated with the spin-off, and higher operating costs.
- Margin Compression: Gross margin decreased from 36% to 32% due to volume increases and inflation in raw materials. Adjusted EBITDA margin declined from 30.2% to 25.1%.
- Segment Performance:
- RAS: Sales up 12% ($711M), but Adjusted EBITDA down 3% ($242M) due to lower margins from refrigerant mix and higher production costs.
- ESM: Sales up 7% ($281M) and Adjusted EBITDA up 10% ($58M), driven by demand growth in electronic materials.
- Transaction Costs: Transaction-related costs decreased to $23 million from $28 million as the company transitions to standalone operations.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects full-year 2026 capital expenditures to be between $400 million and $425 million, up from $62 million in Q1 2025, driven by facility expansions in the ESM segment.
- Dividends: The Board declared a quarterly dividend of $0.075 per share, payable June 10, 2026. The company intends to continue returning cash to shareholders.
- Liquidity: The company maintains $642 million in cash and equivalents and has access to a $1.0 billion revolving credit facility (currently unutilized) and a $1.0 billion term loan. Management believes liquidity is sufficient for the next 12 months.
- Risks: Key risks include geopolitical instability affecting supply chains, inflation in raw material costs, regulatory changes regarding nuclear energy and environmental matters, and the execution of the transition to a standalone public company.
- Legal Proceedings: The company is involved in ongoing litigation regarding its Nuclear Facility in Metropolis, Illinois, including class action lawsuits and property damage claims. Management does not currently anticipate a material adverse effect on financial condition.
Investor Verification Checklist
- Debt Servicing: Verify the impact of the new $2 billion debt load (issued post-spin-off) on future interest expenses and cash flow coverage.
- Standalone Costs: Monitor the trajectory of SG&A expenses as the company fully absorbs costs previously allocated by Honeywell.
- Margin Trends: Assess whether the decline in RAS margins is temporary due to product mix or indicative of sustained pricing pressure.
- Legal Exposure: Review updates on the Metropolis, Illinois nuclear facility litigation and potential environmental liabilities.
- Capital Allocation: Track actual capital expenditures against the $400-$425 million guidance to ensure alignment with growth strategies.